Ancora Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,011
Closed -$2.29M 1407
2019
Q3
$2.29M Buy
23,011
+11,579
+101% +$1.1M 0.1% 204
2019
Q2
$1.06M Sell
11,432
-8,034
-41% -$763K 0.05% 285
2019
Q1
$1.84M Buy
19,466
+3,200
+20% +$280K 0.08% 226
2018
Q4
$1.04M Buy
16,266
+1,130
+7% +$83.4K 0.05% 282
2018
Q3
$1.35M Sell
15,136
-100
-0.7% -$8.84K 0.05% 302
2018
Q2
$1.21M Buy
15,236
+8,932
+142% +$742K 0.05% 307
2018
Q1
$562K Buy
6,304
+1,459
+30% +$140K 0.03% 440
2017
Q4
$506K Sell
4,845
-592
-11% -$66.8K 0.03% 433
2017
Q3
$793K Buy
5,437
+734
+16% +$100K 0.05% 369
2017
Q2
$611K Buy
4,703
+72
+2% +$8.82K 0.04% 387
2017
Q1
$576K Hold
4,631
0.04% 389
2016
Q4
$536K Buy
4,631
+1,618
+54% +$180K 0.04% 389
2016
Q3
$315K Hold
3,013
0.03% 405
2016
Q2
$297K Buy
3,013
+256
+9% +$26.5K 0.03% 387
2016
Q1
$276K Buy
2,757
+43
+2% +$4.43K 0.03% 394
2015
Q4
$325K Buy
2,714
+100
+4% +$11.6K 0.04% 373
2015
Q3
$283K Hold
2,614
0.04% 393
2015
Q2
$303K Buy
+2,614
New +$299K 0.04% 404
2015
Q1
Sell
-7,214
Closed -$862K 281
2014
Q4
$807K Sell
7,214
-1,400
-16% -$148K 0.1% 241
2014
Q3
$816K Sell
8,614
-2,500
-22% -$226K 0.1% 231
2014
Q2
$954K Sell
11,114
-1,000
-8% -$76K 0.12% 206
2014
Q1
$846K Buy
12,114
+114
+1% +$9.03K 0.12% 206
2013
Q4
$1.01M Sell
12,000
-2,400
-17% -$190K 0.15% 169
2013
Q3
$1.11M Sell
14,400
-200
-1% -$14K 0.19% 140
2013
Q2
$854K Buy
+14,600
New +$879K 0.15% 175

Other funds holding CELG

Ancora Advisors's CELG Position: Q4 2019 in Review

Ancora Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,011 shares — an estimated $2.29M sold.

Ancora Advisors first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $2.29M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ancora Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ancora Advisors sold 23,011 Celgene Corp shares in Q4 2019, an estimated $2.29M.
  • Ancora Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Ancora Advisors's Celgene Corp position peaked at $2.29M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ancora Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.